The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Abstract
There are few effective biomarkers for neuroendocrine tumors. Precision oncology strategies have provided liquid biopsies for real-time and tailored decision-making. This has led to the development of the first neuroendocrine tumor liquid biopsy (the NETest). The NETest represents a transcriptomic signature of neuroendocrine tumor (NETs) that captures tumor biology and disease activity. The data have direct clinical application in terms of...
Paper Details
Title
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Published Date
Mar 1, 2020
Journal
Volume
65
Issue
1
Pages
18 - 29
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History